Safety and Health at Work

Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency (산업안전보건연구원)
권호 표지
DOI QR코드

DOI QR Code

Author's Response to Letters to the Editor regarding "Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies"

  • Park, Robert M. (Division of Science Integration, Risk Evaluation Branch, National Institute for Occupational Safety and Health)
  • Published : 2022.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

The author reports that there was no funding source for the work that resulted in the article or the preparation of the article (i.e., only internal U.S. government (CDC/NIOSH) funding).

References

  1. Park RM. Risk assessment for toluene diisocyanate and respiratory disease human studies. Saf Health Work 2021;12(2):174-83. https://doi.org/10.1016/j.shaw.2020.12.002.
  2. Buckley J, Keil A, McGrath L, Edwards J. Evolving methods for inference in the presence of healthy worker survivor bias. Epidemiology 2015;26:204-12. https://doi.org/10.1097/EDE.0000000000000217
  3. Goodman M, Paustenbach D, Sipe K, Malloy CD, Chapman P, Burke ML, Figueroa R, Zhao K, Exuzides KA. Epidemiologic study of pulmonary obstruction in workers occupationally exposed to ethyl and methyl cyanoacrylate. J Toxicol Environ Health 2000;59(3):135-63. https://doi.org/10.1080/009841000156943. Part A.
  4. U. S. Occupational safety and health act; 1970. Section 6(b).
  5. Park RM. Risk assessment for metalworking fluids and respiratory outcomes. Saf Health Work 2019;10(4):428-36. https://doi.org/10.1016/j.shaw.2019.09.001.
  6. Weill H, Butcher B, Dharmarajan V, Glindmeyer H, Jones R, Carr J, et al. Respiratory and immunologic evaluation of isocyanate exposure in a new manufacturing plant. Morgantown, WV: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health; 1981. NIOSH Contract No. 210-75-0006.
  7. Jones RN, Rando RJ, Glindmeyer HW, Foster TA, Hughes JM, O'Neil CE, et al. Abnormal lung function in polyurethane foam producers. Weak relationship to toluene diisocyanate exposures. Am Rev Resp Dis 1992;146(4):871-7. https://doi.org/10.1164/ajrccm/146.4.871
  8. Adams WGF. Long-term effects on the health of men engaged in the manufacture of tolylene di-isocyanate. Br J Indust Med 1975;32:72-8.
  9. Collins JJ, Anteau S, Conner PR, Cassidy LD, Doney B, Wang ML, et al. Incidence of occupational asthma and exposure to toluene diisocyanate in the United States toluene diisocyanate production industry. J Occup Environ Med 2017;59(Suppl. 12):S22-7. https://doi.org/10.1097/jom.0000000000000890.
  10. Middendorf PJ, Miller W, Feeley T, Doney B. Toluene diisocyanate exposure: exposure assessment and development of cross-facility similar exposure groups among toluene diisocyanate production plants. J Occup Environ Med 2017;59(Suppl. 12):S1-12. https://doi.org/10.1097/jom.0000000000001117.
  11. Zeegers M, Antoniou E. Diisocyanate exposure and respiratory health: a quantitative weight of evidence approach of animal and human studies. Submitted for publication in Toxicol Ind Health; 2021.
  12. Wang ML, Storey E, Cassidy LD, Doney B, Conner PR, Collins JJ, Carson M, Molenaar D. Longitudinal and cross-sectional analyses of lung function in toluene diisocyanate production workers. J Occup Environ Med 2021;59(12S):S28-35.
  13. Bodner KM, Burns CJ, Randolph NM, Salazar EJ. A longitudinal study of respiratory health of toluene diisocyanate production workers. J Occup Environ Med 2001;43(10):890-7. https://doi.org/10.1097/00043764-200110000-00008
  14. Omae K, Higashi T, Nakadate T, Tsugane S, Nakaza M, Sakurai H. Four-year follow-up of effects of toluene diisocyanate exposure on the respiratory system in polyurethane foam manufacturing workers. II. Four-year changes in the effects on the respiratory system. Int Arch Occup Environ Health 1992;63(8):565-9. https://doi.org/10.1007/BF00386347
  15. Omae K. Two-year observation of pulmonary function in workers exposed to low concentrations of toluene diisocyanate. Int Arch Occup Environ Health 1984;55(1):1-12. https://doi.org/10.1007/BF00378062
  16. Belin L, Wass U, Audunsson G, Mathiasson L. Amines: possible causative agents in the development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanates. Br J Ind Med 1983;40(3):251-7.
  17. Pinkerton LE, Yiin JH, Daniels RD, Fent KW. Mortality among workers exposed to toluene diisocyanate in the US polyurethane foam industry: update and exposure-response analyses. Am J Ind Med 2016;59:630-43. https://doi.org/10.1002/ajim.22622